EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Are enterococcal bloodstream infections an independent risk factor for a poorer 5-year survival or just a marker for severity of illness?—The Munich multicentric enterococci cohort

Kathrin Rothe iD, Tobias Bachfischer, Siranush Karapetyan, Alexander Hapfelmeier, Milena Wurst, Sabine Gleich, Karl Dichtl, Roland M Schmid, Julian Triebelhorn, Laura Wagner, Johanna Erber, Florian Voit und 7 weitere

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.02585-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Kathrin Rothe und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Medical Microbiology, Immunology and Hygiene, University Hospital rechts der Isar, Technical University of Munich, School of Medicine ,…. Hauptthemen laut MEDLINE: Bacteremia, Gram-Positive Bacterial Infections, Sepsis, Escherichia coli Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To assess the long-term survival of patients with enterococcal bloodstream infections (BSI), encompassing various species and resistance patterns compared to Escherichia coli ( E. coli ) BSI. Between 2010–2019, 3,290 enterococcal and 3,415 E. coli BSI were retrospectively screened in seven hospitals in Munich, Germany. All vancomycin-resistant (VRE), vancomycin/linezolid-resistant (LVRE), and linezolid-resistant (LRE) Enterococcus faecium (ECFM) BSI were included. Enterococcus faecalis (ECFA), vancomycin/linezolid-susceptible ECFM, and E. coli BSI were randomly assigned. Cox regression analysis was used to assess survival as the primary endpoint and was adjusted for limiting prognostic factors, which were measured for their importance using a random forest model (RFM). We analyzed 952 patients with 916 episodes of enterococcal BSI and 193 episodes of E. coli BSI. RFM identified multimorbidity and markers for disease severity as most indicative of low survival in enterococcal BSI. The 5-year survival was significantly lower for enterococcal BSI than for E. coli BSI (23.9% vs 42.3%; P < 0.001). This difference remained significant in the Cox regression analysis after adjusting for 17 prognostic factors and excluding patients with limited life expectancy (metastatic tumor disease, Charlson-Comorbidity-Index ≥5). Adjusted 5-year survival was similar for E. coli and ECFA but significantly different between ECFA and ECFM (29.2% vs 21.7%; P = 0.002). The analysis conducted on monomicrobial ECFM and VRE BSI indicated that their respective 5-year survival was similar (19.6% vs. 21.2%; P = 0.753). ECFM BSI seems to be an independent risk factor for poor long-term survival. However, additional vancomycin resistance does not appear to be a contributing factor. IMPORTANCE The present study provides a substantial contribution to literature, showing that patients with enterococcal bloodstream infections (BSI) have a lower survival rate than those with Escherichia coli ( E. coli ) bloodstream infections after adjusting for 17 limiting prognostic factors and excluding patients with a limited life expectancy [metastatic tumor disease, Charlson Comorbidity Index (CCI) (greater than or equal to) 5]. This difference in the 5-year long-term survival was mainly driven by Enterococcus faecium (ECFM) bloodstream infections, with vancomycin resistance not being a significant contributing factor. Our findings imply that E. faecium bloodstream infections seem to be an independent risk factor for poor long-term outcomes. As such, future research should confirm this relationship and prioritize investigating its causality through prospective studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteremiaGram-Positive Bacterial InfectionsSepsisEscherichia coli InfectionsHumansEnterococcusProspective StudiesEscherichia coliRisk FactorsPatient AcuityAnti-Bacterial Agents

Stichwörter der Autor:innen

5-year survivalEnterococcus faeciumdisease severityenteroccocal bloodstream infectionsvancomycin resistant Entercoccus faecium

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Institute for Medical Microbiology, Immunology and Hygiene, University Hospital rechts der Isar, Technical University of Munich, School of Medicine , Munich, Germany.
  • Department of Internal Medicine II, University Hospital rechts der Isar, Technical University of Munich, School of Medicine , Munich, Germany.
  • Institute of General Practice and Health Services Research, University Hospital rechts der Isar, School of Medicine, Technical University of Munich , Munich, Germany.
  • Institute of AI and Informatics in Medicine, University Hospital rechts der Isar, School of Medicine, Technical University of Munich , Munich, Germany.
  • Public Health Service , City of Munich, Munich, Germany.
  • Max von Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie, Medizinische Fakultät, Ludwig-Maximilians-Universität München , Munich, Germany.

ORCID-Profile: Kathrin Rothe, Jochen Schneider

Zitieren

APA

Rothe, K., Bachfischer, T., Karapetyan, S., Hapfelmeier, A., Wurst, M., Gleich, S., Dichtl, K., Schmid, R. M., Triebelhorn, J., Wagner, L., Erber, J., Voit, F., Burgkart, R., Obermeier, A., Seibold, U., Busch, D. H., Rämer, P. C., Spinner, C. D., & Schneider, J. (2023). Are enterococcal bloodstream infections an independent risk factor for a poorer 5-year survival or just a marker for severity of illness?—The Munich multicentric enterococci cohort. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02585-23

Vancouver

Rothe K, Bachfischer T, Karapetyan S, Hapfelmeier A, Wurst M, Gleich S, et al. Are enterococcal bloodstream infections an independent risk factor for a poorer 5-year survival or just a marker for severity of illness?—The Munich multicentric enterococci cohort. Microbiology Spectrum. 2023. doi:10.1128/spectrum.02585-23

BibTeX
@article{Rothe2023,
  author = {Rothe, Kathrin and Bachfischer, Tobias and Karapetyan, Siranush and Hapfelmeier, Alexander and Wurst, Milena and Gleich, Sabine and Dichtl, Karl and Schmid, Roland M and Triebelhorn, Julian and Wagner, Laura and Erber, Johanna and Voit, Florian and Burgkart, Rainer and Obermeier, Andreas and Seibold, Ulrich and Busch, Dirk H and Rämer, Patrick C and Spinner, Christoph D and Schneider, Jochen},
  title = {Are enterococcal bloodstream infections an independent risk factor for a poorer 5-year survival or just a marker for severity of illness?—The Munich multicentric enterococci cohort},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.02585-23}
}
Kostenlos starten →